SightfileU.S. market data from official filings

Companies › TGTX

TG THERAPEUTICS INC (TGTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001001316 · EDGAR filings · Updated 2026-06-15

TG THERAPEUTICS INC (TGTX) has reported institutional ownership of 68.8%, with 361 institutional managers holding positions valued at $3.50B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
68.8%
Institutional managers
361
Reported 13F value
$3.50B
Insider activity
14 trans.
−$1.20M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TG THERAPEUTICS INC has 361 institutional holders and institutional ownership of 68.8%.

Insider activity

Insiders reported 14 transactions (0 buys, 3 sells) across 7 reporting insiders, with a net reported value of −$1.20M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2023-05-08 (recurring since 2022-08-09) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ACADIA PHARMACEUTICALS INC COM (ACAD) · TWIST BIOSCIENCE CORP (TWST) · TRANSMEDICS GROUP INC (TMDX) · INTEGER HLDGS CORP (ITGR) · DYNE THERAPEUTICS INC (DYN) · STRUCTURE THERAPEUTICS INC (GPCR)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.